Get the app
USHealthcare

Si-Bone Inc (SIBN)

US · Healthcare · Medical Devices

$18.04-2.70%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$56.0M
Revenue YoY
+15.2%
Net profit
$-4.1M
EPS
$-0.09
EPS estimate
$-0.15
Net margin
-7.3%

EPS came in at -0.09 against a street estimate of -0.15 — a beat of 40.0%.

Key statistics

Market cap
$820.2M
Forward P/E
0.0
P/B
4.53
Book value
$4.08
EPS (TTM)
$-0.33
52-week high
$21.89
52-week low
$11.48
50-day MA
$18.18
200-day MA
$16.39
Beta
0.70

Analyst view

Analysts rate Si-Bone Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $25.00.

Shareholding

Insiders
3.27%
Institutions
109.61%

Largest institutional holders

FundStake
First Light Asset Management, LLC18.14%
BlackRock Inc7.65%
Cadian Capital Management LP7.47%
American Century Companies Inc5.60%
Brown Advisory Holdings Inc4.74%
Vanguard Capital Management, LLC3.94%
Granahan Investment Management Inc..3.88%
Arnhold & S. Bleichroeder Advisers, LLC3.43%

Recent filings & reports

DocumentDate
Material agreement · Q3 2026
SI-BONE, INC. - FORM 8-K SUMMARY RISKS & NEGATIVES • Product Recall Initiated: Company voluntarily recalled 98 iFuse TORQ implants on August 21, 202
2026-09-11
Quarterly report · Q2 2026
SI-BONE, INC. – FORM 10-Q SUMMARY (JUNE 30, 2026) HEADLINE NUMBERS • Q2 2026 Revenue: $56.0 million (up 15% vs Q2 2025: $48.6 million) • Six-Month 2
2026-08-04
Results announced · Q3 2026
SI-BONE, INC. Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Worldwide revenue: $56.0 million, up 15.2% year-over-year • U.S. revenue: $53.2 million, u
2026-08-03
Material agreement · Q2 2026
SI-BONE, INC. (SIBN) - FORM 8-K SUMMARY HEADLINE NUMBERS • Company has 44,243,715 shares of common stock outstanding as of April 6, 2026 • 38,905,03
2026-06-08
Quarterly report · Q1 2026
SI-BONE, INC. - Q1 2026 SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Q1 2026 Revenue: $52.6 million, up 11.2% from $47.3 million in Q1 2025
2026-05-11
Results announced · Q2 2026
SI-BONE, INC. Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Worldwide revenue: $52.6 million, up 11.2% year-over-year • U.S. revenue: $49.3 million, u
2026-05-11
Proxy statement · Q4 2025
SI-BONE, INC. PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect two board nominees to serve until the 2029 Annual Meeting.
2026-04-21
Annual report FY2025
SI-BONE, INC. – FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market cap as of June 30, 2025: approximately $0.8 billion (based on non-a
2026-02-24

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Si-Bone Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.